Cargando…
Biotech bubbles during the global recession
Private biotech firms are awash with funding, raising record-breaking sums in 2020. Melanie Senior reports.
Autor principal: | Senior, Melanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016152/ https://www.ncbi.nlm.nih.gov/pubmed/33795889 http://dx.doi.org/10.1038/s41587-021-00876-w |
Ejemplares similares
-
Fresh from the biotech pipeline: too much, too fast?
por: Senior, Melanie
Publicado: (2022) -
Fresh from the biotech pipeline: fewer approvals, but biologics gain share
por: Senior, Melanie
Publicado: (2023) -
Innovators take cover as market bubble bursts
por: Senior, Melanie
Publicado: (2022) -
Second-quarter biotech job picture
por: Francisco, Michael
Publicado: (2022) -
Expanding during a pandemic with the looming threat of recession
por: Pitchforth, Ashkan
Publicado: (2021)